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INT RO DUCT IO N
Adenocarcinoma of the esophagus is increasing in a
number of countries, whereas the incidence of gastric
carcinoma is decreasing1- 7 ). Except for an association with
Barrett's esophagus, little is known about the etiology of
these cancers . Barrett's esophagus is a complication of
gastroesophageal reflux disease (GERD) and is regarded
as an important risk factor of esophageal adenocarcinoma
in western countries8 ). The incidence of esophageal
squamous cell carcinoma has decreased or remains
stable in the USA and European countries, whereas the
incidence of adenocarcinoma is rapidly increasing1 , 2 , 9 ) .
But, the prevalence of esophageal adenocarcinoma has
not been surveyed or reported in Korea, as far as we
know. Therefore, we reviewed the medical records of 969
patients with histologically proven esophageal cancer
during the last three decades (1970- 1999) to assess
indirectly the ratio of esophageal adenocarcinoma to
SCCA.
MAT E R IA LS A ND MET HO DS
Patients with histologically proven esophageal cancer
between 1970 and 1999 were retrospectively studied. The
pathologic diagnosis of esophageal cancer was obtained
by the evaluation of the specimen from surgical resection
or endoscopic biopsy. The data were taken from the
Yonsei Medical Center. The patients were divided into
three consecutive 10-year groups (group 1, 1970- 1979;
group 2, 1980- 1989; group 3, 1990- 1999). Patients with
SCCA or adenocarcinoma that secondarily invaded the
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esophagus from a nonesophageal primary tumor and
patients in whom the esophagus was involved with
metastatic disease were excluded. Esophageal cancers
were divided according to the International Classification
of Diseases of Oncology (ICD- O) morphologic criteria
into adenocarcinoma and non- adenocarcinoma. Three
cell types were defined as follows : adenocarcinoma
group, SCCA group and other cell types, including
neuroendocrine carcinoma, small cell carcinoma and
adenosquamous cell carcinoma. Patients' age at diagnosis,
tumor stage, tumor location, histological type and body
mass index (BMI) were recorded and analyzed.
Statistical analysis
The Statistical Analysis System (SAS Inc., Cary, NC,
USA) was used for all analysis. Trends from the three
groups were compared using chi- square test. The
influence of BMI on two cell types was evaluated with
t- test. The p value less than 0.05 was considered
statistically significant.
R ES ULT S
Between 1970 and 1999, a total of 969 cases of
SCCA, adenocarcinoma, or other cell type cancers in the
esophagus were retrieved in the pathology records at the
Yonsei Medical Center. There were 918 patients with
SCCA and 27 patients with esophageal adenocarcinoma.
Overall, SCCA was the most common cell type. Other
cell types of esophageal cancer consisted of adeno-
squamous carcinoma (n=4), small cell carcinoma (n=2),
neuroendocrine carcinoma (n=1) and undifferentiated type
(n=17). The distribution of the cell types of esophageal
carcinomas is shown in Table 1.
Ta b le 1. The d is tribut io n of the c e ll type s o f
e s o pha ge a l c a rc ino mas
Cell type of esophageal
cancer
Patient
numbers
Percent
Sex
(M:F)
Squamous cell carcinoma
Adenocarcinoma
Undifferentiated
Adenosquamous cell carcinoma
Small cell carcinoma
Neuroendocrine carcinoma
918
27
17
4
2
1
94.7%
2.8%
1.8%
0.4%
0.2%
0.1%
862:56
25:2
17:0
4:0
2:0
1:0
The mean age of patients with esophageal cancer was
61.1±8.8 years (mean age of adenocarcinoma group
and SCCA group, 62.2±10.6 and 61.1±8.7 years ,
respectively) and the mean height and body weight were
166.0±6.7 cm and 53.0±15.9 kg, respectively.
We discovered 541 cases (56.6%) of esophageal
cancer in the mid- esophagus, 207 cases (21.7%) in the
upper esophagus and 207 cases (21.7%) in the lower
esophagus (Table 2). A total of 27 cases of esophageal
adenocarcinoma were identified in this study. The lesion
site of 21 cases was located in the lower esophagus and
that of the remaining 6 cases was located in the
mid- esophagus. The ratios of adenocarcinoma to SCCA
were 10.4% (21/201) in the lower esophagus, 1.1%
(6/529) in the mid- esophagus and 0.0% (0/201) in the
upper esophagus. Thus, adenocarcinoma was located in
the lower esophagus more frequently than in the mid or
upper esophagus with a statistical significance (p =0.001).
Table 2 . The location of e s ophage a l cance rs
Tumor location in
the esophagus
Total SCCA* Adeno†
Other
cell type
Upper 207 (21.7%) 201 0 6
Mid 541 (56.6%) 523 6 12
Lower 207 (21.7%) 180 21 6
Total 955(100.0%) 914 27 24
(miss ing data=14)
SCCA*, squamous cell carcinoma; Adeno† , adenocarcinoma
The ratios of the adenocarcinoma group to the SCCA
group among the three groups were 0.0375, 0.0241 and
0.0292 for group 1, 2 and 3, respectively (p=0.811). The
ratios of the adenocarcinoma group to the SCCA group
have not risen in the three groups (Table 3).
Table 3 . The dis tribution of the e s ophage a l ca nce rs
acco rd ing to the ce ll type s in e ac h gro up
Adenocarcinoma SCCA*
Group 1 (1970- 1979) 3 (3.75%) 77 (96.25%)
Group 2 (1980- 1999) 6 (2.41%) 243 (97.59%)
Group 3 (1990- 1999) 18 (2.92%) 598 (97.08%)
Total 27 918
(p=0.811)
SCCA*, squamous cell carcinoma
In the adenocarcinoma group, the mean BMIwas 19.6±6.3
and that of the SCCA group was 19.4±5.6 (p=0.3445).
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DIS C US S IO N
Our study of esophageal adenocarcinoma has several
limitations in methodology. At first, it is a single center's
experience of 30 years about esophageal cancer and so
the results of this study cannot represent the overall
prevalence of esophageal adenocarcinomas in Korea.
At least seve ral multi- ce nte r studies a re needed for
the purpose of defining the prevalence of esophageal
adenocarcinoma in Korea. But our study tried to find
indirect evidence of an increasing tendency of esophageal
adenocarcinoma and the result seems to be that the
ratio of adenocarcinoma to SCCA has not increased in
patients with esophageal carcinoma in a the past three
decades in single medical center in Korea.
From the late 1970s, a significant increase in the
incidence of adenocarcinoma of the esophagus and
gastric cardia has been reported from many countries ,
including the US 1- 3 ) , the United Kingdom4 ) , France5 ) and
Sweden6 ) . In the US, adenocarcinoma of the esophagus
has continued to increase in frequency in the early 1990s
and an estimated 25,000 people die every year of this
cancer7 ) . Lord et al. reported from a large scale
prevalence study done in 199810 ) that the incidence of
esophageal adenocarcinoma in men has increased
evidently in Australia . The incidence of SCCA of the
esophagus is mostly stable or decreasing whilst that of
adenocarcinoma of the esophagus has been reported to
be increasing in incidence in a number of regions 1 , 2 , 9 ) .
These two types of esophageal cancer have distinctly
different demographic patterns (i.e., the incidence of
squamous cell tumors is more than 5 times higher
among black men than among white men, whereas the
incidence for adenocarcinoma is more than three times
higher in white men compared with black men).
Although adenocarcinoma of the esophagus has been
increasing rapidly in many regions of the world, the risk
factors of the cancer are largely unknown. The proposed
candidates as risk factors for adenocarcinoma of the
esophagus are Barrett's esophagus, high BMI, alcohol
and tobacco use, H2 receptor antagonist use, Helicobacter
pylori (H. pylori) infection, etc.
Adenocarcinomas of the esophagus can possibly arise
from mucosal glands, submucosal glands, ectopic gastric
mucosa a nd Ba rrett's esophagus . Ra re cases of
esophageal adenocarcinomas in the upper esophagus
have been described in the literature 1 1) .
The recently reported increasing incidence of adeno-
carcinomas in the lower esophagus is related to malignant
transformation of Barrett's esophagus. In Barrett's esoph-
agus, the normal squamous epithelial lining of the lower
esophagus, damaged by gastroesophageal reflux, is
replaced by columnar epithelium. Barrett's esophagus is
a precursor lesion for adenocarcinoma of the esophagus
and gastric cardia and is more common in men12 ) . Patients
with Barrett's esophagus have a 30∼125 times increased
risk of developing esophageal carcinoma 13 - 15 ). Barrett's
esophagus is thought to arise in conditions with prolonged
reflux of duodenal contents into the esophagus 16 - 18 ) .
It is believed that GERD is more common in obese
patients , especially those with abdominal obesity. Brown
et al. reported that obesity (upper quartile of BMI) was
associated with a three times higher risk of adenocarcinoma
than the lowest quartile19 ). The mechanism by which obesity
might affect the risk of esophageal adenocarcinoma is
unclear, a lthough it may be linked to the predisposition
of obese individuals to GERD and to the commonly
associated hiatal hernia2 0 ) . Reflux esophagitis is a major
risk factor for Barrett's esophagus2 1) , which in turn is a
precursor lesion for esophageal adenocarcinoma. As for
BMI, our observation showed no stastistically significant
difference between adenocarcinoma and SCCA groups
(BMI of the adenocarcinoma group=19.6, BMI of the
SCCA group=19.4, p =0.8331).
There is no report on the prevalence and incidence of
reflux esophagitis in the general Korean population. In
Korea, it is generally accepted that the prevalence and
incidence of reflux esophagitis are lower than those in
the western countries . Yi et al. found that the estimated
age- adjusted prevalence of endoscopically- proven reflux
esophagitis in a general health screening population was
2.7%, which was very low prevalence compared to those
from western countries2 2 ) . The study of Yeom et al. also
showed that the prevalence of reflux esophagitis in
patients with symptoms of gastrointestinal tract was 5.4%,
which means that the prevalence of reflux esophagitis in
the Korean population would be much lower than that of
western countries2 3 ) . But it is expected that GERD in Korea
may increase in incidence because of the increase in the
obese population due to westernized diet and life style.
In conclusion, unlike the western countries including
US, our retrospective study found that the ratio of
adenocarcinoma to SCCA has not increased in patients
with esophagea l carcinoma in the past three decades
at a single medical center in Korea. However, further
epide miologic studies a re needed to eva luate the
possibility of an increasing tendency to develop esophageal
adenocarcinoma in Korea in the near future.
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